Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
about
The direct cost of epilepsy in the United States: A systematic review of estimatesExtended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulationsThe effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulationImproving patient-centered care coordination for children with epilepsy: version 2.0 upgrade required.The impact of a pharmacist-led educational interview on medication adherence of Saudi patients with epilepsyAdherence to antiepileptic drugs among children attending a tertiary health unit in a low resource setting.Psychiatric and medical admissions observed among elderly patients with new-onset epilepsy.A mixed methods analysis of support for self-management behaviors: perspectives of people with epilepsy and their support providersAdherence to antiepileptic drugs and beliefs about medication among predominantly ethnic minority patients with epilepsy.Spatial patterns of epilepsy-related emergency department visits in california.Health care charges for youth with newly diagnosed epilepsy.White coat adherence over the first year of therapy in pediatric epilepsy.Quality of Antiepileptic Treatment Among Older Medicare Beneficiaries With Epilepsy: A Retrospective Claims Data Analysis.Uninformed clinical decisions resulting from lack of adherence assessment in children with new-onset epilepsyMedicine possession ratio as proxy for adherence to antiepileptic drugs: prevalence, associations, and cost implications.Preliminary feasibility, acceptability, and efficacy of an innovative adherence intervention for children with newly diagnosed epilepsy.Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventionsAntiepileptic Drug Nonadherence and Its Predictors among People with Epilepsy.Self-management in epilepsy: Why and how you should incorporate self-management in your practiceExtended-release lamotrigine in the treatment of patients with epilepsy.Overcoming problems with adherence to osteoporosis medication.Ideal characteristics of an antiepileptic drug: how do these impact treatment decisions for individual patients?Safety issues around misuse of antiepileptics.Applying a perceptions and practicalities approach to understanding nonadherence to antiepileptic drugs.Insight: An ontology-based integrated database and analysis platform for epilepsy self-management research.Justification for conducting neurological clinical trials as part of patient care within private practice.Quality Indicator for Epilepsy Treatment 15 (QUIET-15): Intervening after recurrent seizures in the elderly.Adherence to antiepileptic drugs among diverse older Americans on Part D Medicare.EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure.Adherence to antiepileptic drugs in children with epilepsy in a Scottish population cohort.The influence of socioeconomic status on health resource utilization in pediatric epilepsy in a universal health insurance system.Clinic-Based Mobile Health Decision Support to Enhance Adult Epilepsy Self-Management: An Intervention Mapping Approach.Variation in antiepileptic drug adherence among older patients with new-onset epilepsy.Economic impact of medication non-adherence by disease groups: a systematic review.The Stability and Influence of Barriers to Medication Adherence on Seizure Outcomes and Adherence in Children With Epilepsy Over 2 Years.Medication adherence and adverse effect profile of antiepileptic drugs in Nigerian patients with epilepsy.Population Pharmacokinetic Evaluation and Missed-Dose Simulations for Eslicarbazepine Acetate Monotherapy in Patients With Partial-Onset Seizures.Epilepsy is associated with unmet health care needs compared to the general population despite higher health resource utilization--a Canadian population-based study.The impact of nonadherence to antiseizure drugs on seizure outcomes in an animal model of epilepsy.Reduction of emergency department visits using an urgent clinic for children with established epilepsy.
P2860
Q26799129-F7C64108-9048-468A-97FD-45E3D4C5D54DQ27027410-7CDD67BD-06EB-41D1-90A6-49D1532C5C9FQ33571434-AD0944EF-FE16-4EB9-99CF-441DAB3336B3Q33684721-C5B26AF3-E029-4EDF-A2F8-5C9DD2D708EAQ33719205-698CD1A1-CB62-4001-857B-99C85AE5CAAFQ33860089-AC24EF88-57FB-46FF-9DDD-75DB9EDD10A4Q33876913-1E626D3D-4EF4-40F3-AD4F-2C18BC1A940EQ34124986-5E1C06A1-6982-4FD9-8E30-CC426B3ADA5FQ35500970-F202DE28-B6D2-4CAE-8574-6BB3DB5B6E61Q35529427-78B31F9E-7B2B-4CAE-B440-F78613AC0ACFQ35966442-C54E062C-1F56-496D-B39A-DA77C5109A41Q36185865-4C960DA9-1167-4401-91E5-C12F33C0E84EQ36355039-33DD0FD8-47F1-413E-A292-FAA9DD79B37CQ36443286-8D19DE75-B2EF-4291-B726-1AADC59FEAEEQ36808200-C41D73EE-CCC2-47BE-830F-4C3773599394Q36981570-E3543BE8-1219-4D21-A4F1-648E7229DD19Q37014474-F6CEC00E-B9AF-4829-8A4B-15430C820657Q37526902-C6075E9B-014D-4145-B263-0E78CE638452Q37738208-2AD364D1-88EC-4E76-9A75-03607B18CF55Q37756144-1B49AFE4-6318-4CD3-9711-56369B021785Q37820680-39E2725A-1686-4D55-A85D-5C3D54963CE7Q38056165-E5A00D33-1007-4DC3-9857-BBB970F4244FQ38103947-E148CA49-29B2-4A3F-844D-1D712B6264A2Q38442798-581B23F5-BA1B-44DA-A8EF-2FF348FDC354Q38443347-E8CF0307-99C1-45DF-BE55-24ACC487752CQ38797002-4D2B82CD-1B1E-40CB-BCFE-E34F03C6DBD9Q38835688-FDA90672-5DDA-4183-8503-4C0FFCBF580AQ39050442-93CBB759-FD30-4954-901C-35700A31A904Q39116160-C11C79B8-78D3-4655-B111-CEEC6DFEB769Q40369996-19D5B2B2-047E-4E21-8F33-D486D4F30331Q40965753-A494A2EF-CB85-45E7-ABBE-50D97A89A682Q42372556-6671155F-3261-485F-84A0-45D734C5572CQ42838449-64346B34-8E9C-4151-ADF9-76DCD643D728Q47555825-E42FA2AD-35EB-4F2C-8F10-1B7E1B8A3A41Q47759704-D72FD86F-ED60-4C68-B39E-AE3D786D9E3AQ50141567-77EE11A1-C0A2-4D24-8ADE-193950E787EFQ50205952-2CC1D147-4DB3-4778-AACD-5CDB9C1008EBQ50773922-0694E262-E825-43B1-AC09-2CF4844745F6Q53628827-F6CF6120-887A-489A-B49F-20C3F2A01ADDQ55208822-1C87654E-26E8-4695-BFF0-3D40B0146A46
P2860
Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of nonadherence to anti ...... indings from the RANSOM study.
@en
Impact of nonadherence to anti ...... indings from the RANSOM study.
@nl
type
label
Impact of nonadherence to anti ...... indings from the RANSOM study.
@en
Impact of nonadherence to anti ...... indings from the RANSOM study.
@nl
prefLabel
Impact of nonadherence to anti ...... indings from the RANSOM study.
@en
Impact of nonadherence to anti ...... indings from the RANSOM study.
@nl
P2093
P1433
P1476
Impact of nonadherence to anti ...... indings from the RANSOM study.
@en
P2093
Jennifer R Weiner
Marianne C Cunnington
Mei Sheng Duh
R Edward Faught
P304
P356
10.1111/J.1528-1167.2008.01794.X
P50
P577
2008-10-03T00:00:00Z